UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000016176
Receipt number R000018777
Scientific Title Feasibility study on dose-dense paclitaxel and carboplatin therapy in combination with bevacizumab as neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
Date of disclosure of the study information 2015/01/13
Last modified on 2021/10/30 15:51:47

No. Disposal Last modified on Item of update
1 Insert 2015/01/10 12:19:57
2 Update 2018/01/13 16:48:43 Name of primary person or sponsor
Organization
3 Update 2018/07/15 14:56:57 Recruitment status
4 Update 2018/07/15 15:04:33 Organization
Organization
Organization
Institute
Organization
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
5 Update 2019/07/16 08:23:27 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/07/16 08:25:02 Number of participants that the trial has enrolled
7 Update 2019/07/16 08:28:00 Date of IRB
Last follow-up date
8 Update 2021/01/14 18:39:42 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2021/01/14 18:55:41 URL releasing protocol
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
10 Update 2021/10/30 15:48:35 Recruitment status
11 Update 2021/10/30 15:51:47 URL releasing protocol
Publication of results
URL related to results and publications
Date of the first journal publication of results